RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$2B
1-Year Return
22.93%
This Quarter Return
+26.68%
1 Year Return
+22.93%
3 Year Return
+109.5%
5 Year Return
+168.49%
10 Year Return
+483.96%
AUM
$1.14B
AUM Growth
+$265M
(+30%)
Cap. Flow
+$56.3M
Cap. Flow
% of AUM
4.92%
Top 10 Holdings %
Top 10 Hldgs %
35.71%
Holding
219
New
26
Increased
98
Reduced
67
Closed
10
Top Buys
| 1 |
Carrier Global
CARR
|
$10.1M |
| 2 |
Apple
AAPL
|
$6.8M |
| 3 |
Walt Disney
DIS
|
$3.75M |
| 4 |
Microsoft
MSFT
|
$3.68M |
| 5 |
Sysco
SYY
|
$3.38M |
Top Sells
| 1 |
Novartis
NVS
|
$3.12M |
| 2 |
MarketAxess Holdings
MKTX
|
$2.1M |
| 3 |
Envista
NVST
|
$1.8M |
| 4 |
Teladoc Health
TDOC
|
$1.77M |
| 5 |
IPG Photonics
IPGP
|
$1.64M |
Sector Composition
| 1 | Healthcare | 28.32% |
| 2 | Technology | 20.78% |
| 3 | Industrials | 11.48% |
| 4 | Financials | 11.02% |
| 5 | Communication Services | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Gilead Sciences
GILD
$143B
| $1.01M | 0.09% |
13,056
+1,459
| +13% | +$112K |
|
102
JPMorgan Chase
JPM
$809B
| $1M | 0.09% |
10,643
-214
| -2% | -$20.1K |
|
103
Ionis Pharmaceuticals
IONS
$9.76B
| $981K | 0.09% |
16,640
-1,750
| -10% | -$103K |
|
104
Applied Materials
AMAT
$130B
| $948K | 0.08% |
15,680
+2,108
| +16% | +$127K |
|
105
Emerson Electric
EMR
$74.6B
| $924K | 0.08% |
14,888
-2,400
| -14% | -$149K |
|
106
IBM
IBM
$232B
| $906K | 0.08% |
7,843
-340
| -4% | -$39.3K |
|
107
S&P Global
SPGI
$164B
| $822K | 0.07% |
2,496
+46
| +2% | +$15.1K |
|
108
Arthur J. Gallagher & Co
AJG
$76.7B
| $819K | 0.07% |
+8,404
| New | +$819K |
|
109
Blackrock
BLK
$170B
| $819K | 0.07% |
+1,505
| New | +$819K |
|
110
Mercado Libre
MELI
$123B
| $812K | 0.07% |
+824
| New | +$812K |
|
111
Adobe
ADBE
$148B
| $804K | 0.07% |
1,847
+291
| +19% | +$127K |
|
112
Target
TGT
$42.3B
| $804K | 0.07% |
6,706
+1,777
| +36% | +$213K |
|
113
DTE Energy
DTE
$28.4B
| $782K | 0.07% |
8,543
| – | – |
|
114
Kimberly-Clark
KMB
$43.1B
| $782K | 0.07% |
5,535
-142
| -3% | -$20.1K |
|
115
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
| $779K | 0.07% |
9,850
| – | – |
|
116
Colgate-Palmolive
CL
$68.8B
| $768K | 0.07% |
10,487
+134
| +1% | +$9.81K |
|
117
Brookfield Renewable
BEP
$7.06B
| $760K | 0.07% |
+29,791
| New | +$760K |
|
118
Medtronic
MDT
$119B
| $750K | 0.07% |
8,174
+2,225
| +37% | +$204K |
|
119
Vanguard Small-Cap Growth ETF
VBK
$20.4B
| $705K | 0.06% |
3,530
-300
| -8% | -$59.9K |
|
120
SPDR S&P Dividend ETF
SDY
$20.5B
| $692K | 0.06% |
7,591
| – | – |
|
121
Descartes Systems
DSGX
$9.26B
| $661K | 0.06% |
12,500
+3,540
| +40% | +$187K |
|
122
WisdomTree US LargeCap Dividend Fund
DLN
$5.26B
| $650K | 0.06% |
14,000
| – | – |
|
123
Mettler-Toledo International
MTD
$26.9B
| $648K | 0.06% |
804
-67
| -8% | -$54K |
|
124
GSK
GSK
$81.5B
| $644K | 0.06% |
+12,628
| New | +$644K |
|
125
Boston Scientific
BSX
$159B
| $633K | 0.06% |
18,037
-697
| -4% | -$24.5K |
|